Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Medtronic
McKesson
Johnson and Johnson
Harvard Business School

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

ZANTAC 75 Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Zantac 75, and when can generic versions of Zantac 75 launch?

Zantac 75 is a drug marketed by Sanofi Us and is included in two NDAs.

The generic ingredient in ZANTAC 75 is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and thirty-two suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Zantac 75

A generic version of ZANTAC 75 was launched as ranitidine hydrochloride by ANI PHARMS INC on December 14th, 2019.

Drug patent expirations by year for ZANTAC 75
Recent Clinical Trials for ZANTAC 75

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
Nova Scotia Health AuthorityPhase 4
Lisa BarrettPhase 4

See all ZANTAC 75 clinical trials

Recent Litigation for ZANTAC 75

Identify potential future generic entrants

District Court Litigation
Case NameDate
Lakewood Health System v. TriWest Healthcare Alliance Corp.2007-02-07
APOTEX INC. v. FOOD AND DRUG ADMINISTRATION2006-11-06
AstraZeneca AB v. Dexcel Ltd.2006-05-30

See all ZANTAC 75 litigation

Synonyms for ZANTAC 75
({5-[(2-{[(1E)-1-(methylamino)-2-nitrovinyl]amino}ethylthio)methyl](2-furyl)}m ethyl)dimethylamine
(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine hydrochloride
(E)-N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamin
(E)-N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
(E)-N-(2-(((5-((dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine hydrochloride
(E)-N-(2-((5-((dimethylamino)methyl)furan-2-yl)methylthio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
(E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
(E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
(E)-N1'-[2-[[5-(dimethylaminomethyl)-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine
(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine hydrochloride
(E)-N1'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
(E)-N1'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine hydrochloride
[(E)-1-({2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine hydrochloride
1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-
1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-, hydrochloride
1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-, monohydrochloride
1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-
1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-, (E)-
357N593
357R355
66357-35-5
66357-59-3
71130-06-8
A830929
A835434
A835435
AB00052223_11
AB00052223_12
AB00052223-10
AB02807
AB1009310
AB2000300
AC-12712
AC-12743
AC1MHDJB
AC1MHVLK
AC1Q1WQX
AC1Q38JI
Achedos
Acidex
AH 19065
AH 19065;Zantac
AH-19065
AH19065
AKOS005552967
AKOS015895250
Alquen
Alter-H2
Alvidina
API0004039
Apo-Ranitidin
Artomil
Atural
Axoban
Azantac
Azuranit
BCP21325
BCP28420
BDBM22893
BDBM237183
BIDD:GT0179
BIM-0051043.0001
Biotidin
BRD-K70505054-001-02-9
C13H22N4O3S
C13H22N4O3S.HCl
CAS-66357-35-5
CAS-66357-59-3
CCG-212946
CCG-39025
CCRIS 5268
CHEBI:8776
CHEBI:8777
CHEBI:92246
CHEMBL1092473
CHEMBL512
Coralen
Coralen [inj.]
CPD000653467
CS-2293
D00422
D00673
DB00863
Digestosan
dimethyl[(5-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine
DSSTox_CID_25191
DSSTox_GSID_45191
DSSTox_RID_80738
DTXSID0052835
Duractin
EINECS 266-332-5
EINECS 266-333-0
EINECS 275-207-4
Epitope ID:127515
Epitope ID:127516
Ergan
Esofex
EU-0101073
Ezopta
Fendibina
Gastrial
Gastridina
Gastrolav
Gastrosedol
Gavilast
GGWBHVILAJZWKJ-KJEVSKRMSA-N
GTPL1234
HMS1568J03
HMS1921L07
HMS2092H15
HMS501F22
HSDB 3925
HY-B0281A
I06-0246
I06-2377
I09-0405
IDI1_000440
Istomar
J10378
KB-277588
KB-80331
KS-5230
Kuracid
L000504
Label
Lake
Logast
Logat
Lopac-R-101
Lopac0_001073
LP01073
LS-67645
LS-67646
Mauran
MFCD00069339
Microtid
Mideran
MLS001146938
MLS002548856
MolPort-003-666-370
MolPort-003-959-435
MolPort-028-751-168
MolPort-044-723-992
N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, hydrochloride
N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitrovinylidenediamine hydrochloride
N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitrovinylidenediamine monohydrochloride
N-[(E)-1-(Methylamino)-2-nitroethenyl]-2-[[[2-[(dimethylamino)methyl]-5-furanyl]methyl]thio]ethanamine
N-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine
N-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine hydrochloride
N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethylenediamine
N-[2-[[5-[(dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitrovinylidenediamine hydrochloride
N-[2-[5-[(Dimethylamino)methyl]furfurylthio]ethyl]-N'-methyl-2-Nitro-1,1-ethenediamine Hydrochloride
n-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-n'-methyl-2-nitroethene-1,1-diamine hydrochloride(1:1)
N'-[2-[[5-(Dimethylaminomethyl)-2-furyl]methylsulfanyl]ethyl]-N-methyl-2-nitro-ethene-1,1-diamine hydrochloride
N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine
NC00479
NCGC00015876-01
NCGC00015876-02
NCGC00015876-03
NCGC00015876-04
NCGC00015876-05
NCGC00015876-06
NCGC00015876-07
NCGC00015876-08
NCGC00015876-09
NCGC00015876-11
NCGC00018108-01
NCGC00018108-02
NCGC00018108-03
NCGC00024387-02
NCGC00094351-01
NCGC00094913-01
NCGC00094913-02
NCGC00094913-03
NCGC00094913-04
NCGC00094913-05
NCGC00256269-01
NCGC00261758-01
Neugal
Noctone
Noktome
Normon
Novo-Radinine
NSC-757851
NSC757851
Nu-Ranit
Pep-Rani
Pharmakon1600-01501151
Prestwick_635
Prestwick2_000201
Ptinolin
Quadrin
Quantor
Quantor [inj.]
Quicran
R-101
R0073
Radin
Radinat
RAN
Ran H2
Ran Lich
Randin
Rani 2
Rani AbZ
Rani-BASF
Rani-nerton
Rani-Puren
Rani-Q
Rani-Sanorania
Raniben
Raniberl
Raniberta
Ranibeta
Ranibloc
ranic
Ranicux
Ranidil
Ranidin
Ranidine
Ranidura
Ranifur
Ranifur [inj.]
Ranigasan
Ranigast
Ranigen
Ranilonga
Ranimerck
Ranin
Raniogas
Raniplex
Ranisan
Ranisen
Ranitab
Raniter
Ranitic
Ranitidin
Ranitidin 1A Pharma
Ranitidin AL
Ranitidin Arcana
Ranitidin Atid
Ranitidin AWD
Ranitidin Basics
Ranitidin Duncan
Ranitidin Dyna
Ranitidin Helvepharm
Ranitidin Heumann
Ranitidin Hexal
Ranitidin Merck
Ranitidin Millet
Ranitidin NM
Ranitidin Normon
Ranitidin PB
Ranitidin Stada
Ranitidin von ct
Ranitidin-Cophar
Ranitidin-Isis
Ranitidin-ratiopharm
Ranitidina
Ranitidina [INN-Spanish]
Ranitidina predilu Grif
Ranitidina Tamarang
ranitidine
Ranitidine (Form I And Form Ii)
Ranitidine (hydrochloride)
Ranitidine (TN)
Ranitidine (USAN/INN)
Ranitidine (Zantac)
Ranitidine [USAN:BAN:INN]
Ranitidine Base
Ranitidine HCL
Ranitidine HCL 1/2 Type
ranitidine hydrochloride
Ranitidine hydrochloride (JP17/USP)
Ranitidine Hydrochloride [USP:JAN]
ranitidine.hcl
Ranitidinum
Ranitidinum [INN-Latin]
Ranitiget
Ranitin
Ranitine
Ranobel
Rantacid
Rantidine
Ranuber
Ratic
Raticina
Regalil
Renatac
RND
Rozon
Rubiulcer
s1801
SAM002264645
Sampep
Santanol
SBB006527
SBI-0051043.P003
SC-19601
SC-45877
Serviradine
SMR000653467
Sostril
SPECTRUM1501151
Spectrum5_001189
SR-01000075288
SR-01000075288-2
SR-01000075288-3
ST050299
STK619092
SW196800-3
Tanidina
Taural
Terposen
Tocris-1967
Toriol
Tox21_110250
Tox21_110250_1
Tox21_302372
Tox21_501073
Trigger
Ul-Pep
Ulcecur
Ulceranin
Ulcex
Ulcirex
Ulcodin
Ulcolind Rani
Ulsaven
Ultidine
Urantac
Verlost
Vesyca
Viserul
Vizerul
VMXUWOKSQNHOCA-UKTHLTGXSA-N
W-104534
Weichilin
Weidos
Xanidine
Zandid
Zantab
ZANTAC
Zantac (TN)
Zantac 150
ZANTAC 300
Zantac In Plastic Container
Zantadin
Zantarac
Zantic
ZINC1530728

US Patents and Regulatory Information for ZANTAC 75

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020745-001 Feb 26, 1998 DISCN Yes No   Start Trial   Start Trial   Start Trial
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995 OTC Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZANTAC 75

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995   Start Trial   Start Trial
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995   Start Trial   Start Trial
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.